Jagsonpal Pharmaceuticals Limited Share Price & Stock Analysis

Jagsonpal Pharmaceuticals Limited (NSE: JAGSNPHARM, BSE: 507789) is a Gurugram, Haryana-based company in the Pharmaceuticals industry. With a market capitalisation of ₹1,429 Cr, it ranks #1,413 by market cap among the 6,197 Indian listed companies on FinBizNet, and #22 of 63 in Pharmaceuticals. At ₹216.30 (as of 16 Nov 2026), the share price is 18.2% below its 52-week high of ₹264.50 and 39.5% above its 52-week low of ₹155.00. The share price is up 0.1% over one year and down 6.0% over three months.

Key Metrics

Current Price₹216.30
Market Cap₹1,429 Cr
NSE SymbolJAGSNPHARM
BSE Code507789
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio34.6
Return on Equity16.69%
Return on Assets10.22%
52-Week Range₹155.00 – ₹264.50
1-Year Price Change+0.1%
3-Month Price Change-6.0%
Beta (1Y)0.23
Dividend Yield1.15%
HeadquartersGurugram, Haryana
Websitewww.jagsonpal.com

Latest Quarterly Results — Q2 FY27

Revenue₹96 Cr
Net Profit₹12 Cr
Net Margin12.8%
EPS (Basic)₹1.86
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Shareholding and Delivery

Promoters held 68.81% of Jagsonpal Pharmaceuticals Limited's shares as of Sept 2026, against 67.54% in Sept 2025 (+1.27 percentage points). Delivery averaged 49.7% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Jagsonpal Pharmaceuticals Limited

Jagsonpal Pharmaceuticals Limited engages in the manufacturing, selling, and trading of pharmaceutical products and active pharmaceutical ingredients in India and internationally. It offers pharmaceutical formulations and products in the areas of gynaecology, orthopaedics, dermatology, and paediatrics. The company provides drugs in the form of tablets, softgels, injections, capsules, and syrups. Jagsonpal Pharmaceuticals Limited was incorporated in 1978 and is based in Gurugram, India.

Products and Services

1. Pharmaceuticals-This segment manufactures and sells pharmaceuticals and intermediate drugs.

Business Segments

1. Manufacturing and Trading of Pharmaceutical Products-100%

Jagsonpal Pharmaceuticals Limited vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Jagsonpal Pharmaceuticals Limited₹1,429 Cr34.616.69%₹96 Cr+0.1%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Jagsonpal Pharmaceuticals Limited?

Jagsonpal Pharmaceuticals Limited is trading at ₹216.30, with a market capitalisation of ₹1,429 Cr.

Which sector does Jagsonpal Pharmaceuticals Limited belong to?

Jagsonpal Pharmaceuticals Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Jagsonpal Pharmaceuticals Limited?

Jagsonpal Pharmaceuticals Limited has a P/E of 34.6 and a return on equity of 16.69%.

What is the stock symbol of Jagsonpal Pharmaceuticals Limited?

Jagsonpal Pharmaceuticals Limited is listed on the NSE under the symbol JAGSNPHARM and on the BSE under the scrip code 507789.

How has Jagsonpal Pharmaceuticals Limited's share price moved over the past year?

Jagsonpal Pharmaceuticals Limited's share price is up 0.1% over one year and down 6.0% over three months. Its 52-week range is ₹155.00 to ₹264.50.

What were Jagsonpal Pharmaceuticals Limited's latest quarterly results?

In Q2 FY27, Jagsonpal Pharmaceuticals Limited reported revenue of ₹96 Cr and net profit of ₹12 Cr, with basic EPS of ₹1.86 (consolidated, parsed from the company's exchange filing).

What is the promoter holding in Jagsonpal Pharmaceuticals Limited?

Promoters held 68.81% of Jagsonpal Pharmaceuticals Limited's shares as of Sept 2026, against 67.54% in Sept 2025 (+1.27 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.